This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Prescribing Information link can be found at the top and bottom of this page, and Adverse Event reporting statement can be found at the bottom of this page.

This summer, how can GSK help you deliver the non-seasonal shingles National Immunisation Programme?

This is a promotional webinar organised and funded by GSK for UK Healthcare Professionals or other relevant decision makers only. GSK products will be discussed. Please do not forward on. Expert led virtual webinar covering the importance of completing the two-dose shingles vaccination course. Another focus is how to embed a consistent approach to set your practice up to proactively offer shingles vaccination as soon as your patients become eligible, all year round.

Register for the following sessions

23 May, 2024

13:00 GMT+01:00

24 May, 2024

13:00 GMT+01:00

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.